Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab
Publication Date
2019
Journal Title
Blood
Volume Number
133
Issue Number
19
Pages
2031 - 2042
Document Type
Article
Status
Faculty
Facility
School of Medicine
Primary Department
General Internal Medicine
PMID
DOI
10.1182/blood-2018-08-870238